Skip to main content
Year archive

Mezzion Pharma Co., Ltd. — 2024 filings

All 22 regulatory filings released by Mezzion Pharma Co., Ltd. (140410) in 2024, sourced directly from the official regulator.

22 Filings
2024 Period
2024 filings (22)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2024-12-16 Korean
타법인주식및출자증권취득결정
Capital/Financing Update
2024-12-16 Korean
분기보고서 (2024.09)
Interim / Quarterly Report 9M 2024
2024-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2024-10-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2024-09-03 Korean
반기보고서 (2024.06)
Interim / Quarterly Report H1 2024
2024-08-13 Korean
[기재정정]반기보고서 (2024.06)
Interim / Quarterly Report H1 2024
2024-08-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2024-07-03 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2024-06-19 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Q1 2024
2024-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2024-04-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2024-04-23 Korean
[첨부추가]투자판단관련주요경영사항(임상시험계획변경승인) (폰탄환자치료제 유데나필의 임상3상(추가 임상) 임상시험 계획 변경승인)
Regulatory Filings
2024-04-08 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2024-03-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2024-03-19 Korean
[기재정정]감사보고서제출
Audit Report / Information FY 2023
2024-03-19 Korean
감사보고서제출
Audit Report / Information FY 2023
2024-03-18 Korean
사업보고서 (2023.12)
Annual Report FY 2023
2024-03-18 Korean
주주총회소집결의
AGM Information
2024-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2024-03-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2023
2024-02-22 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2024-01-05 Korean